Mitochondria are controlled by both nuclear and mitochondrial genomes therefore, there are several very unique features of the mitochondrial genome. Mitochondrial DNA comprises 0.1-2% of the total DNA in most mammalian cells. MtDNA consists of a 16.5 kb doublestranded circular DNA molecule that is maternally inherited (Anderson et al. 1981) . MtDNA has 2 strands: a guanine-rich heavy strand (or outer strand) and cytosine-rich light strand (or inner strand). The comprision of ETC 13 polypeptide genes can be classified as fallow: 1. MtDNA also encodes the 12S and 16S rRNA genes, and the 22 tRNA genes, which are required for mitochondrial protein synthesis. MtDNA encodes 7 subunits (ND1, 2, 3, 4, 4L, 5, and 6) of the 46 subunits constituting complex I, one of 11 subunits of complex III, 3 of 13 subunits of complex IV, and 2 of 17 subunits of complex V (Reddy PH and Beal MF, 2005) . The rest of the polypeptides of the ETC complexes, including all the subunits of Complex II (succinate dehydrogenase), as well as approximately 1500 other proteins which function in mitochondria are encoded by nuclear genes, synthesized in the cytosol and imported into mitochondria through various protein import systems. 2. Genetic information is not distributed equally on the two mtDNA strands. The two mtDNA strands can be separated by denaturing cesium chloride gradient centrifugation (Kasamatsu H, and Vinograd J, 1974) . Most of the information is encoded in the heavy (purine-rich) strand. The light (pyrimidine-rich) strand contains genetic information for only one polypeptide and eight tRNAs. 3. Mitochondrial genes have no introns and intergenic sequences are absent or limited to a few bases. Some genes overlap and in some instances, termination codons are not encoded (Ojala D, et al., 1981) . 4. Human mtDNA is exclusively inherited through the maternal lineage. Mitochondria from spermatozoa penetrate to the ovum but they are selectively marked with ubiquitin and apparently removed (Sutovsky P et al.1999) . It has been recently found that even before the elimination of the spermatozoa mitochondria, the mtDNA is degraded (Nishimura Y. et al. 2006) .Spermatozoa are germinal cells but the behavior of their mitochondria is similar to that of somatic cells. They are very active (E. Ruiz-Pesini et al 2007) and produce many mutagenic reactive oxygen species (ROS). Thus, by removing the paternal mtDNA, the possibility of transmitting mtDNA mutations decreases enormously. In fact, the only known human paternal contribution to the next generation is associated with a pathologic mutation in the mtDNA (M. Schwartz et al 2002) . 5. Mitochondria do not have histones. However, mammalian mtDNA is organized in nucleoids, which can be seen under the microscope as punctuate structures containing mtDNA and proteins which localize to the matrix surface of the mitochondrial inner membrane. Another important piece of information about mtDNA is whether this genome is totally dependent upon nuclear-encoded proteins for its maintenance and transcription. Regarding replication, mtDNA replicates throughout the lifespan of an organism in both proliferating and post-mitotic cells in order to maintain a constant supply of genetic material so that mitochondria can undergo continuous turnover. 6. Mammalian mitochondria have multi-copies of own genome (approximately 103 to 104 copies/cell). Mitochondria which is replicated and expressed within mitochondria (Clayton, 1982 (Clayton, , 1984 . 7. While the ovum has about 100,000 copies of mtDNA, during oogenesis, the number of mtDNA molecules that will populate the next generation is very small, with estimates ranging as low as one to a few mtDNA genomes (known as the "bottleneck") (Wallace www.intechopen.com DC, et al 2001and Howell N, et al 2000 . Thus, a heteroplasmic mother frequently will have children with widely different average levels of mutant heteroplasmy. 8. Unlike nuclear genes in which there are usually two copies per cell, mtDNA is at high copy number with hundreds to tens of thousands of copies per cell (Smeitink J, et al 2001) . Thus, while in nuclear genetics there are homozygotes (100% mutant) and heterozygotes (50% mutant) within mtDNA, mutant proportions can vary anywhere between 0% and 100% across the spectrum (e.g., 0.42% or 78.3% mutant). When two (and very rarely more) mtDNA sequences coexist in the same mitochondrion, cell, tissue or individual, the term "heteroplasmy" is applied. In clinical diagnostics, one usually discusses heteroplasmy as consisting of a "wild-type" (normal) mtDNA sequence and a "mutant" (disease-associated) mtDNA sequence, although this is not always the case as benign polymorphisms can also be heteroplasmic, in other words, both mtDNA sequences may be unrelated to disease (Tzen CY, et al 2001) . 9. A critical number of mutated mtDNAs must be present before tissue dysfunction and clinical signs become apparent, so-called threshold effect. Tissues with high requirements for oxidative energy metabolism, such as muscle, heart, brain, and neurosensory organs have relatively low thresholds and are particularly vulnerable to mtDNA mutations.
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Mitochondrial disorders
Hereditary mitochondrial disorders are caused by mutations in the mtDNA, or nuclear DNA (nDNA), resulting in impaired respiratory chain activity or oxidative phosphorylation. Phenotypically, mitochondrial disorders present as single or multi system diseases, with onset between birth and senescence (Zeviani M, Di DonatoS 2004) . Mitochondrial disorders usually have a progressive course which is why single organ affection turns into multisystem affection during the disease course. Mitochondrial disorders manifest in tissues/organs with high-energy demand (Montirosso R, et al.2002) and are aggravated by fever, infection, stress, or certain drugs (Longo N. 2003) . Systems/organs most frequently clinically or sub-clinically affected in mitochondrial disorders are the peripheral nervous system, the central nervous system (CNS), endocrine glands, heart, ears, eyes, gastrointestinal tract, liver, kidneys, bone marrow, and dermis (Finsterer J. 2004) .Various combinations of organ affection constitute mitochondrial syndromes for which well-known acronyms have been adopted. The second most frequently affected system is the CNS (Finsterer J et al 2001) . Similar to other organs, the CNS may be affected alone or together with one or several other tissues. Most frequently the CNS is affected together with the skeletal muscles for which the term _encephalomyopathy_ was coined (Riggs JE, et al 1984 , Leonard JV, Schapira AHV 2000 . The frequency of mtDNA diseases is high. It has been estimated that one out of approximately 8000 individuals harbors a pathogenic mtDNA mutation . Mitochondrial diseases are mostly caused by defects in the enzymes involved in respiration and OXPHOS (Wallace D.C, 1999 , Gupta, 2001 , Spees, J et al 2006 , DiMauro, S., Schon, E. A 2003 . They may arise from mutations in nuclear DNA or mtDNA. It has been documented that some mitochondrial diseases are caused by specific mutations in nuclear genes, which are involved in the replication and maintenance of mtDNA and respiratory chain function of mitochondria. These diseases may be resulted from defects in the citric acid cycle, -oxidation of fatty acids, the urea cycle, and the respiration and OXPHOS system, respectively.
A striking feature of mtDNA disorders is their clinical heterogeneity, ranging from singleorgan involvement to severe multisystem disease. The same mutation or different mutations in the same mtDNA gene may present with very different clinical manifestations while the same clinical phenotype may be caused by different mutations. This variability in clinical manifestation may be due to several factors, including the ratio of wild-type to mutant mtDNA, varying thresholds of biochemical expression for both the mutation and the tissue involved, and the modulating effect of nuclear and other mitochondrial genes. Since 1988, more than 100 distinct mtDNA point mutations have been identified in patients with diverse clinical phenotypes (Schon EA, et al 2002. and Servidei S, 2002) . the following: cardiac conduction defects, cerebellar ataxia or CSF protein greater than 100 mg/dl. Some patients have additional manifestations, including dementia or endocrinopathies. These patients may develop additional features such as deafness, diabetes, endocrine dysfunction, and behavioural disorders. The prognosis is much worse than that for isolated CPEO, and few patients survive beyond the age of 30. Isolated limb myopathy is a frequent manifestation of mtDNA disorders, taking the form of a proximal limb weakness with fatigue. Deterioration is usual but it is slow and the patient is unlikely to need a wheelchair. This spectrum of phenotypes is often caused by a single large mtDNA deletion, especially the 5-kb "common deletion", but additional possibilities include deletion/duplications and mtDNA point mutations including A3243G .
Organ system
Leber's hereditary optic neuropathy (LHON)
1. LHON is the commonest cause of blindness in healthy young men. It is maternally inherited and manifests in late adolescence or early adulthood as bilateral sequential visual failure. 90% of patients are affected by age 40 and virtually all by age 50. Although the disease is usually confined to the optic nerve some patients also have cardiac conduction defects or encephalopathic features, particularly dystonia. The preponderance of males (about 80%) among LHON patients and the high proportion of symptomless carriers have prompted the suggestion that factors other than mtDNA mutations contribute to pathogenesis. LHON is usually caused by homoplasmic mtDNA mutations (100% mutant); the most common are G11778A, G3460A and T14484C . Penetrance is low, and males are three to four times more likely to become blind than females.
Encephalomyopathies
Any combination of encephalopathic features (dementia/mental retardation, ataxia, seizures, myoclonus, deafness, dystonia) may occur alone, in combination, or in association with myopathy. However, certain syndromes have emerged that remain a useful means for classification even though the syndromes may overlap considerably.
Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS)
is probably the commonest of the mitochondrial encephalomyopathies. This syndrome is characterized by stroke-like episodes, often reversible, with onset generally between age 5-15 years but can be anywhere between infancy and adulthood. Most cases are caused by heteroplasmy for the A3243G mutation; however, T3271C, other heteroplasmic mtDNA point mutations, large rearrangements and presumed nuclear defects (with normal mtDNA) can cause the MELAS phenotype. Ragged-red fibers and abnormal electron transport chain activities are frequently absent, particularly in younger children. Although the A3243G mutation is usually thought of as being causal for MELAS, the mutation is more often associated with maternally inherited diabetes, deafness, cognitive impairment, short stature and/or migraine, as well as a wide variety of other disease manifestations (Wallace DC, et al 200; Shah NS, et al 2002; Harrison TJ, et al 1997; and Majamaa K, et al 1998) . 2. Leigh syndrome Also called subacute necrotizing encephalopathy, this disorder is characterized by cranial nerve abnormalities, respiratory dysfunction and ataxia with hyperintense signals on T2-weighed images in the basal ganglia, cerebellum or brain stem. Age of onset is from infancy to early childhood. As in many other mitochondrial disorders, Leigh disease is usually but not always progressive and lethal, and progression often occurs associated with infection. There is significant genetic heterogeneity, including mutations on both genomes. Very high mutant loads of the T8993G/C mtDNA mutation (usually > 95%) are one common cause of Leigh syndrome. The most common nuclear DNA related causes of Leigh disease are complex I deficiency (including NDUFV1 mutations), complex IV deficiency (including SURF1 mutations), and PDHC deficiency .
3. Myoclonic epilepsy and ragged-red fiber disease (MERRF) this syndrome consists of progressive epilepsy and dementia, with onset in late childhood or adulthood. Most cases have heteroplasmy for A8344G, a point mutation in the tRNA lysine gene. Some patients have multiple symmetrical lipomatosis, which are large subcutaneous fat masses, usually located around the neck (Shoffner JM. 2001) . Ragged-red fibers refer to subsacrolemmal collections of mitochondria that stain red on modified Gomori trichrome stain. They are present in many patients with different presentations of mitochondrial disease but are not common in affected children. Myoclonus may occur in association with generalized seizures. The prognosis is variable but a useful pointer is the mutant load in the blood. Casali C, et al. 1999) , astatic seizures (Toyono M, et al. 2001) , or juvenile myoclonic epilepsy (Minassian BA, et al.1995) . In adultpatients myoclonic jerks or focal or generalized epilepsy may occur (Arenas J, et al. 1999; , Mitani M, et al. 2000) . In single cases epilepsy a partial is continua have been reported (Balestri P, Grosso S. 2000) . Epilepsy is particularly prevalent inpatients with MELAS, MERRF, LS, or NARP. Epidemiological studies have shown that epilepsy patients are more likely to have affected mothers than fathers. It is a well-known fact that epileptic seizures can be presenting signs of mitochondrial dysfunction in the central nervous system. Thus, generalized seizures have been observed in several forms of myoclonus epilepsy associated with mutations in the mitochondrial DNA polymerase (POLG) (Naviaux and Nguyen 2004; Zsurka et al. 2008) , mitochondrial tRNALys (MT-TK) (Shoffner et al. 1990; Zeviani et al. 1993 ) and tRNAPhe (MT-TF) (Zsurka et al.2010 ) genes. Partial seizures are frequently noticed in mitochondrial encephalopathies, including the MELAS syndrome, associated with mutations in the mitochondrial tRNALeu gene (MT-TL1) (Goto et al. 1990 ). More recently, evidence for a more general involvement of mitochondria also in sporadic forms of epilepsy has been accumulated (Kann et al. 2005; Kunz et al. 2000; Kunz 2002 ). This might be related to the fact that mitochondria are intimately involved in pathways leading to neuronal cell death (Krajewski et al. 1999; Blümcke et al. 1999) as seen in experimental and human epilepsy. On the other hand, more recent data substantiate the evidence, that mitochondrial dysfunction might play a direct pathogenic role in the process of epileptogenesis and seizure generation in certain types of epilepsy. The clinical syndrome was first recognized by Fukuhara et al.(1980) , when he described the "canonical" signs of 1) myoclonus, 2) generalized tonic clonic and absence seizures, 3) ataxia, and 4) ragged red fibres in the muscle biopsy. MERRF usually starts in childhood but it is not uncommon in adults. Deafness in PME should make one consider MERRF, especially if dementia, dysarthria short stature, optic atrophy, neuropathy, lactic acidosis, hypoventilation, and migraine are present. Inheritance is consistent with mitochondrial (maternal) transmission. Muscle biopsy demonstrates subsarcolemmal aggregates of mitochondria, the so-called ragged-red Fibres. Giant visual evoked potentials are recorded in all cases. Shoffner et al. (1990) were the first to demonstrate the typical A-to-G substitution at nucleotide 8344 in the mitochondrial DNA, which affects the pseudouridine loop of the mitochondrial tRNALys. The A8344G mutation is present in 90% of patients with MERRF. Two other mutations (T8356C and G8363A) in the tRNAlys gene have also been associated with MERRF. How these mutations produce the disease phenotype is unclear, although it is suspected to be a defect of oxidative energy production.
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MELAS, mitochondrial encephalomyopathy, lactic acidosis, stroke-like episodes; MERFF, myoclonic epilepsy and ragged red fibers; LS, Leigh syndrome, maternally inherited Leigh syndrome; LHON, Leber's hereditary optic neuropathy; KSS, Kearns-Sayre syndrome; NARP, neurogenic muscle, weakness, ataxia, and retinitis pigmentosa; Table 6 . Genetic heterogeneity of mitochondrial disease with CNS involvements MERRF syndrome is a devastating neuromuscular disorder characterized by myoclonic epilepsy, general weakness, muscle wasting, cerebellar ataxia, deafness, and dementia transmitted through maternal lineages (Shoffner JM et al 1990) . Additional manifestations such as short stature, optic atrophy, peripheral neuropathy, cardiomyopathy, myoglobinuria, and renal tubular dysfunction have also been documented (ErolI et al 2009) Common clinical manifestations include myopathy, neuropathy, hearing loss, dementia, short stature, and optic atrophy. Less commonly, cardiomyopathy, pigmentary retinopathy, pyramidal signs, ophthalmoparesis, multiple lipomas, and diabetes mellitus can occur. (Chinnery PF et al. 1997) There is an overlap with the syndrome of MELAS, but MERRF usually has a longer course and is associated with milder behavioural and cognitive deficits. (DiMauro S et al. 2002) In patients with MERRF, the EEG shows generalised spike-and-wave discharges at 2-5 Hz, with background slowing that progress as the disease advances. Focal epileptiform discharges can also be seen. (So N. et al. 1989 ) Muscle biopsy shows ragged red fibres in over 90% of patients. ( Hirano M et al 1996) Biochemical studies of respiratory-chain enzymes in www.intechopen.com
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muscle extracts usually show decreased activity. ( Boulet L et al. 1992 ) Besides, lactate and pyruvate are commonly elevated in serum at rest and increased excessively after moderate physical activities (Ozawa M et al 1995) . Brain MRI may show brain atrophy and basal ganglia calcifications. (DiMauro S et al. 2002) Grey-matter signal changes on T2-weighted images are sometimes seen, with deep cerebral nuclei being more involved than the cerebral cortex. When signal changes are seen in the white matter, the peripheral white matter is the earliest to beinvolved. (BarkovichAJ et al 1993) . When myoclonus and myoclonic seizures are combined with deafness, ataxia, and neuromyopathy, MERRF should be considered. Table 7 . Spectrum of MERRF Syndrome
Debilitating if not fatal, these epileptic encephalopathies are characterized by the triad of myoclonus, epilepsy, and progressive neurologic deterioration. Myoclonus or myoclonias consist of stimulus sensitive, segmental or par cellar, arrhythmic, and asynchronous lightning like muscular jerks that affect any muscle group in the body. Epilepsy is also stimulus sensitive and consists of generalized tonic± clonic or clonic±tonic±clonic seizures (grand mal) and absences. Neurologic deterioration consists of mental decline leading to dementia, cerebellar ataxia, and various progressive neurologic manifestations, depending on the cause.
Genetics and diagnosis
The most common molecular defect is an adenosine to guanine substitution at nucleotide pair 8344 (8344A→G) in the tRNALys gene of mitochondrial DNA. (Shoffner JM et al 1990) Although few less frequent point mutations of mtDNA were also found in MERRF patients (Virgilio R et al 2009, and Blakely EL et al 2009) . Besides, molecular genetic studies of several MERRF pedigrees and biochemical studies of skin fibroblasts showed a positive correlation between the A8344G mutation in the tRNALys gene of mtDNA and the reduction in the activities of respiratory enzyme Complexes I and IV (James AM et al. 1996 and 1999) . Another rare identified molecular cause of MERRF is a tyrosine to cytosine substitution (8356T→C) in the same gene, (Silvestri G et al. 1992 ) and another is a guanine to adenosine substitution (8363G→A). (Santorelli FM et. Al 1996) However, in some individuals, a mutation has not been identified. Clinical clues to the presence of MERRF include deafness, optic atrophy, myopathy, lipomas, intrafamilial variation in age of onset, and maternal transmission. Ragged red fibres and mutations in germline DNA (eg, peripheral blood) can be used to confirm the diagnosis. (Hammans SR et al. 1991) Defects in mitochondrial respiratory enzyme Complexes I and IV accompanied with RRF are the most prominent biochemical defects in the muscle of MERRF patients (Antonická H et al 1999) Phenotype Mitochondrial gene Mutations References MELAS tRNALeu(UUR) A3243G, T3271C,A3252G, C3256T,A3260G, T3291C (Goto et al., 1990 (Goto et al., , 1991 (Goto et al., ,1994 Morten et al., 1993; Nishino et al., 1996; Sato et al., 1994 ) tRNAPhe G583A (Hanna et al., 1998 ) tRNAVal G1642A (Taylor et al., 1996 ) tRNAGln G4332A (Bataillard et al., 2001 ) tRNACys A5814G (Manfredi et al., 1995 ) tRNALys A8296G,T8316C, T8356C (Campos et al., 2000; Sakuta and Nonaka, 1989; Zeviani et al., 1993 ) COX III T9957C (Manfredi et al., 1996) (Taniike et al., 1992; Santorelli et al., 1997 ) ME with recurrent episodes of epilepsia partialis continua tRNASer(UCN T7512C (Jaksch et al., 1998; Schuelke et al., 1998) COX I C6489A (Varlamov et al., 2002 ) Leigh syndrome ATP6 T8993G,T8993C (Canafoglia et al., 2001; De Vries et al., 1993 ) tRNALys G8363A (Shtilbans et al., 2000 ) LHON ND1 G3460A ) ND2 C4640A ME -mitochondrial encephalopathy; MERRF -myoclonus epilepsy with 'ragged redfibers'; MELAS -mitochondrial encephalopathy with lactic acidosis and stroke-likeepisodes; PEO -progressive external ophthalmoplegia; LHON -Leber's hereditaryoptical neuropathy; RC -respiratory chain. Table 9 . Epilepsy phenotypes in patients with nuclear gene-related mitochondrial disorders Table modified according to M. Hirano et al. (2008) . Table 10 . Clinical-genetic classification of mitochondrisl disorders.
Mitochondrial dysfunction not only decreases the production of ATP but also increases the reactive oxygen species (ROS) generation through the electron leak from the respiratory chain in mitochondria (James AM et al. 1996 and 1999) . Consequently, enhanced oxidative stress and oxidative damage have been often observed in the affected tissues of MERRF patients (Bacman SR et al. 2003) . Normally, the expression and activity levels of antioxidant enzymes are induced to change so prevent cells from ROS-induced oxidative damage. Longterm exposure to ROS of the affected cells in MERRF patients may initiate and expedite a vicious cycle to result in further increase of ROS production and enhanced oxidative damage to DNA, RNA, lipids, and proteins in mitochondria (Liu CY et al 2009) . Nuclear disease genes associated with mitochondrial disease can be provisionally classified into four groups: (1) genes encoding structural components of OXPHOS complexes; (2) genes encoding assembly factors of OXPHOS complexes; (3) genes altering the stability of mitochondrial DNA; (4) genes encoding factors involved in the biogenesis of mitochondria, including OXPHOS. A8296G mutation was found in MT-TK and Ahadi et al (2008) suggest that this mutation is a rare polymorphism or may be a pathogenic mutation in combination with other mutations outside of the MT-TK gene.
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Therapy
Mitochondrial dysfunction has been identified as a potential cause of epileptic seizure and therapy-resistant forms of sere epilepsy. Experimental and human studies have suggested that excessive free radical generation and a deficient antioxidant system are directly or indirectly implicated as taking part in the pathogenesis of epilepsy, resulting in seizure recurrence and resistance to treatment with antiepileptic drugs. Antiepileptic drugs alter the neuronal oxidative status and increase membrane lipid peroxidation, leading to the increase risk of seizure recurrence. Epileptic patients and experimental animals with the antioxidant supplementations, such as vitamin E, melatonin and resveratrol, improve the oxidative damage in mitochondrial dysfunction. Hence, the antioxidant supply is beneficial for the prevention of mitochondrial dysfunction and recurrence of epilepsy. In addition, the detection of brain oxidative status is important for predicting the prognosis of patients with medication or surgery. In MERRF patients with secondary cytochrome-c oxidase deficiency intravenous administration of copper has been reported to be beneficial (Ohinata J, et al 2002) . Seizures in mitochondrial diseases can be effectively treated with conventional antiepileptic drugs. If possible, however, valproate should be avoided because of its mitochondrial and liver toxicity and its hematological side effects. In addition, carbamazepine or oxcarbamazepine should be avoided because of its liver toxicity and its hematologic side effects, particularly in mitochondrial diseases patients who frequently also manifest with anemia, leucopenia, or thrombocytopenia. Furthermore, carbamazepine and oxcarbamazepine may cause or worsen hyponatriemia, and thus increase the risk of triggering further seizures. According to personal observations, topiramate may worsen wasting in mitochondrial diseases patients with myopathy. The most well tolerated antiepileptic drugs appear to be lamotrigine, gabapentin, lorazepam, and levetirazetam. For acute seizure control intravenous valproate is sometimes inevitable. Other options for intravenous antiepileptic acute therapy are lorazepam or phenytoin. In single cases with resistance to antiepileptic drugs succinate (6 g/day) may reduce seizure frequency. Uncinatus crises in MELAS can be effectively resolved with lorazempam. 
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